G. Butora

发表

Post-Synthetic Modification of Oligonucleotides via Orthogonal Amidation and Copper Catalyzed Cycloaddition Reactions.

V. Jadhav, D. Tellers, D. Zewge, 2018, Bioconjugate chemistry.

Synthesis of 2′-β-C-methyl-neplanocin derivatives as anti-HCV agents

M. Maccoss, G. Butora, D. Olsen, 2008 .

siRNA-optimized Modifications for Enhanced In Vivo Activity

A. Willingham, W. Flanagan, F. Soriano, 2012, Molecular therapy. Nucleic acids.

NEW CHIRAL SYNTHONS FROM THE MICROBIAL OXIDATION OF BROMONAPHTHALENES

T. Hudlický, G. Butora, Mary Ann A. Endoma, 1996 .

Cyclic-disulfide-based prodrugs for cytosol-specific drug delivery.

G. Butora, I. Davies, T. Nguyen, 2014, Angewandte Chemie.

Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.

M. Struthers, M. Maccoss, J. Demartino, 2009, Bioorganic & medicinal chemistry letters.

Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists.

M. Struthers, J. Demartino, G. Butora, 2008, Bioorganic & medicinal chemistry letters.

Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2'-C-methyladenosine.

M. Maccoss, G. Butora, D. Olsen, 2007, Bioorganic & medicinal chemistry.

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties.

M. Maccoss, G. Butora, D. Guiadeen, 2006, Bioorganic & medicinal chemistry letters.

Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.

M. Maccoss, W. Hanlon, G. Butora, 2006, Bioorganic & medicinal chemistry letters.

Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.

M. Maccoss, G. Butora, W. Parsons, 2007, Journal of medicinal chemistry.

Toward a Practical Synthesis of Morphine. The First Several Generations of a Radical Cyclization Approach

G. Butora, 1998 .

Chemoenzymatic synthesis of the morphine skeleton via radical cyclization and a C10C11 closure

T. Hudlický, K. Abboud, S. Fearnley, 1996 .

A Historical Perspective of Morphine Syntheses

T. Hudlický, S. Fearnley, G. Butora, 1995 .

Nucleophilic substitution of protected β-bromoethyl cyclohexadiene-cis-diol as an alternative to direct microbial oxidation of β-functionalized phenethyl substrates

T. Hudlický, G. Butora, Mary Ann A. Endoma, 1996 .

Oxidation of 2‐(2‐bromoethyl)bromobenzene with toluene dioxygenase: Isolation and identification of new chiral synthons

T. Hudlický, S. Fearnley, G. Butora, 1995 .

The elusive 8-fluoroadenosine : a simple non-enzymatic synthesis and characterization

M. Maccoss, G. Butora, G. Doss, 2007 .

Concise preparation of 8-trifluoromethyltetrahydro-6H-pyrido [1,2-a] pyrazine-6-one

M. Maccoss, G. Butora, D. Guiadeen, 2009 .

3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.

G. Butora, W. Parsons, Hong Jin, 2007, Bioorganic & medicinal chemistry letters.

Nucleoside optimization for RNAi: a high-throughput platform.

W. Flanagan, G. Butora, I. Davies, 2011, Journal of the American Chemical Society.

Intramolecular Diels–Alder reactions of the furan diene (IMDAF); rapid construction of highly functionalised isoquinoline skeletons

T. Hudlický, S. Fearnley, G. Butora, 1995 .